Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Patanjali ads...

    Patanjali ads unsubstantiated, misleading: Advertising Standards Council of India

    Written by savita thakur thakur Published On 2016-07-05T13:10:51+05:30  |  Updated On 5 July 2016 1:10 PM IST

    New Delhi : Advertising watchdog ASCI has once again pulled up yoga guru Baba Ramdev promoted Patanjali Ayurved for running "misleading" ad campaigns that disparages competitors' products.


    The Advertising Standards Council of India (ASCI) said that Patanjali Ayurved "unfairly denigrates" products of its rivals in the advertisements.


    The Consumer Complaints Council (CCC) found that Patanjali's claim for its 'Kachi Ghani Mustard Oil' that rival makers are selling mustard oil "adulterated with oil made by solvent extraction process with neurotoxin containing Hexane", was not substantiated.


    "Also, the claim is grossly misleading by exaggeration," the ad regulator said in its list for the month of April, 2016, in which it upheld 67 complaints against several companies.


    Besides, Patanjali also failed to substantiate its claims for Patanjali Fruit Juice, where it had claimed rival brands as "expensive juices containing less pulp".


    According to the regulator, the ad was accompanied by reference to the prices of other branded juices and "by implication unfairly denigrates the entire class/category of fruit juices".


    Similarly, it also failed to substantiate its claims in the ad for cattle feed 'Patanjali Dugdhamrut' as "other companies mix 3 to 4 per cent urea and other non-edible things in their cattle feed."


    ASCI also held Patanjali Ayurved's ads for toothpaste 'Patanjali Dant Kanti' as misleading as it did not substantiate claims of it being effective against pyorrhoea, swelling and bleeding of gums, yellowing of teeth, sensitivity and bad breath and provides a natural shield against germs.


    When contacted, a Patanjali Ayurved spokesperson said the company is looking into the details and exploring legal options in this matter.


    "We are looking into the details and are in talks with the legal department," he said.


    In May this year, ASCI had rapped Patanjali Ayurved for "false and misleading" claims in its various advertisements, including its hair oil and washing powder brands, while issuing list for month of March.


    ASCI has also pulled up companies like Nissan Motors, Tata Motors, Amazon, Pernod Ricard India, Reckitt Benckiser, Colgate-Palmolive, Procter & Gamble Hygiene & Health Care, Hindustan Unilever, Idea Cellular, Reliance Industries.


    It upheld complaints against an ad of Nissan Sunny, where Nissan Motors has shown the driver speaking on the phone, vehicles coming from the wrong sides, car overtaking from the wrong side and the driver not wearing seat belt.

    Advertising Standards Council of IndiaASCIBaba RamdevCCCConsumer Complaints CouncilmisleadingPatanjaliPatanjali Ayurved Ltdunsubstantiated
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok